Skip to content
Disclosery

Lunate Capital Ltd

Follow

13F filer, CIK 2056786, AL MARYAH ISLAND, ABU DHABI, United Arab Emirates

Lunate Capital Ltd reported $264,258,501 across 6 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-01-23.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001011438-26-000036

Period
2025-12-31
Reported value
$264M
Holdings
6
Top 10 weight
100%
New
1
Sold out
1

Part of the filer group Lunate Capital Ltd

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NAVNnew+200,000$3.42M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
FIGRexited-680,000-$24.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0001011438-26-000036, largest first. % of portfolio is the value over $264,258,501, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 2,196,200 shares; 2025Q2: 2,196,200 shares; 2025Q3: 2,196,200 shares; 2025Q4: 2,196,200 shares 2,196,200$175M66.2%0Timeline
SAILSAILPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 3,000,000 shares; 2025Q2: 3,000,000 shares; 2025Q3: 3,000,000 shares; 2025Q4: 3,000,000 shares 3,000,000$60.7M22.97%0Timeline
LINELINEAGE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 600,000 shares; 2025Q2: 600,000 shares; 2025Q3: 600,000 shares; 2025Q4: 600,000 shares 600,000$21M7.95%0Timeline
NMRANEUMORA THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: 2,124,143 shares; 2025Q2: 2,124,143 shares; 2025Q3: 2,124,143 shares; 2025Q4: 2,124,143 shares 2,124,143$3.8M1.44%0Timeline
NAVNNAVAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 200,000 shares 200,000$3.42M1.29%newTimeline
RVMDWREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not loaded; 2024Q4: not loaded; 2025Q1: not reported; 2025Q2: 450,000 shares; 2025Q3: 450,000 shares; 2025Q4: 450,000 shares 450,000$423K0.16%0Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
FIGRFIGURE TECHNOLOGY SOLUTIO680,000$24.7Mshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001011438-26-000036 base2026-01-23acceptance time not in the bulk data set